Login to Your Account

Other News To Note

Thursday, August 18, 2011
Cynapsus Therapeutics Inc., of Toronto, said it plans to proceed with its all-stock acquisition of Hamilton, Ontario-based Adagio Pharmaceuticals Ltd., its partner on APL-130277, a reformulation of an approved Parkinson's drug.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription